Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Amortizatization of Intangibles of $12122.0 in Q1 2026, down 12.92% quarter-over-quarter from $13921.0 in Q4 2025, and up 85.49% on a YoY basis from $6535.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $12122.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 85.49% year-over-year to $12122.0; the TTM figure through Mar 2026 stood at $659978.0 (up 3.05% YoY), while the FY2025 annual figure was $62030.0, down 94.25% from the prior year.
- Amortizatization of Intangibles was $12122.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $13921.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $606974.0 in Q3 2022 to a low of -$508121.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $265399.4 across 5 years, with a median of $316967.5 in 2024.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles sank 3676.3% in 2022, then soared 337.84% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$508121.0 in 2022, then jumped by 192.17% to $468325.0 in 2023, then plunged by 47.17% to $247430.0 in 2024, then tumbled by 94.37% to $13921.0 in 2025, then declined by 12.92% to $12122.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $12122.0 (Q1 2026), $13921.0 (Q4 2025), and $247430.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Shuttle Pharmaceuticals Holdings | 2.43 Mn | 1.36 Mn | - | 12,122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,122.00 |
| Mar 31, 2026 | 12,122.00 |
| Dec 31, 2025 | 13,921.00 |
| Dec 31, 2025 | 13,921.00 |
| Sep 30, 2025 | 247,430.00 |
| Sep 30, 2025 | 247,430.00 |
| Jun 30, 2025 | 386,505.00 |
| Jun 30, 2025 | 386,505.00 |
| Mar 31, 2025 | 6,535.00 |
| Mar 31, 2025 | 6,535.00 |
| Sep 30, 2024 | 247,430.00 |
| Sep 30, 2024 | 247,430.00 |
| Jun 30, 2024 | 386,505.00 |
| Jun 30, 2024 | 386,505.00 |
| Mar 31, 2024 | 445,509.00 |
| Mar 31, 2024 | 445,509.00 |
| Dec 31, 2023 | 468,325.00 |
| Dec 31, 2023 | 468,325.00 |
| Sep 30, 2023 | 538,302.00 |
| Sep 30, 2023 | 538,302.00 |